Cases started on MDR-TB treatment in Belarus
Belarus: Cases started on MDR-TB treatment was 520 in 2024. ◆ Volatile
Cases started on MDR-TB treatment in Belarus, 2010–2024
Source: World Health Organization, Global Health Observatory.
Analysis
Belarus recorded 520 for cases started on mdr-tb treatment in 2024.
Compared with earlier readings it is down 17.9% on the previous year and down 72.7% over ten years.
Over the whole period, cases started on mdr-tb treatment in Belarus peaked at 2,478 in 2012 and was at its lowest, 200, in 2010.
That places Belarus 28th out of 193 countries with data for 2024, putting it in the top quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Cases started on MDR-TB treatment in Belarus, year by year
| Year | Value | Change |
|---|---|---|
| 2010 | 200 | — |
| 2011 | 1,446 | +623.0% |
| 2012 | 2,478 | +71.4% |
| 2013 | 2,154 | -13.1% |
| 2014 | 1,903 | -11.7% |
| 2015 | 1,949 | +2.4% |
| 2016 | 1,362 | -30.1% |
| 2017 | 1,074 | -21.1% |
| 2018 | 933 | -13.1% |
| 2019 | 1,059 | +13.5% |
| 2020 | 811 | -23.4% |
| 2021 | 728 | -10.2% |
| 2022 | 790 | +8.5% |
| 2023 | 633 | -19.9% |
| 2024 | 520 | -17.9% |
Belarus compared with similar countries
- Belarus's 520 is above the median for upper middle income countries, which is 40, 13.0× the median. (57 countries reporting)
- Belarus's 520 is above the median for Europe & Central Asia, which is 12.5, 41.6× the median. (48 countries reporting)
Biggest year-on-year movements
Years where Cases started on MDR-TB treatment in Belarus changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2011 | +623.0% | 200 | 1,446 |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 1,456 | 200 | 2,478 | 10 |
| 2020s | 696.4 | 520 | 811 | 5 |
Countries ranked near Belarus
- 25 Kyrgyzstan 725 compare
- 26 Nepal 633 compare
- 27 Turkmenistan 627 compare
- 29 Cote d'Ivoire 465 compare
- 30 Afghanistan 464 compare
- 31 South Korea 461 compare
More health data for Belarus
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.3867 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,674 deaths per 1,000 people (2090)
- Number of infants who die before age 1 18 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -5.57 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.019 units per person (2025)
- Population ages 00-04, male, annual growth rate -5.56 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is cases started on mdr-tb treatment in Belarus?
- Cases started on mdr-tb treatment in Belarus was 520 in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest cases started on mdr-tb treatment recorded in Belarus?
- The highest recorded value was 2,478 in 2012.
- What is the lowest cases started on mdr-tb treatment recorded in Belarus?
- The lowest recorded value was 200 in 2010.
- How does Belarus rank for cases started on mdr-tb treatment?
- Belarus ranks 28th out of 193 countries with data for 2024.
- Is cases started on mdr-tb treatment rising or falling in Belarus?
- Over the last ten years it is down 72.7%. The long-run trend across the full record is volatile.
- Where does this Belarus data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Cases started on MDR-TB treatment. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 15 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).